Feuille James sold CHYM

Footnotes

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.38 to $33.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.; The shares held by Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") as reported herein reflect the receipt of shares pursuant to pro rata distributions in kind, effected by CB VII and CB VII-B, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.; The shares held by CV VII Hldgs as reported herein reflect pro rata distributions in kind, effected by CV VII Hldgs to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.; Shares are directly held by CV VII Hldgs. The Reporting Person is a managing member of CV VII Hldgs and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.